Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic exposure in early infancy and immune responses to rotavirus vaccination
2022-001541-20Phase 4Completed
- Start
- May 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (2 arms). Primary endpoints: Specific salivary IgA levels against rotavirus and Specific serum IgA levels against rotavirus. Started May 2024; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2022-001541-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001541-20.